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The regulatory axis between the iron hormone hepci-
din and its receptor, the iron exporter ferroportin
(FPN), is central to iron homeostasis. Mutations
preventing hepcidin-mediated degradation of FPN
cause systemic iron overload. We have introduced
a point mutation (C326S) into the murine Fpn locus,
resembling human hereditary hemochromatosis
type 4, including elevated plasma iron and ferritin
levels, high transferrin saturation, hepatic iron over-
load, and iron depletion of duodenal enterocytes
and reticuloendothelial macrophages. Unlike other
mouse models of iron overload, homozygous
C326S mice die between 7 and 14 months of age.
Pancreatic acinar cells display marked iron accumu-
lation, oxidative damage and degeneration, associ-
ated with failure of the exocrine pancreas and severe
body weight loss. Rescue experiments reveal iron
overload and exocrine pancreatic failure as leading
causes of death. This work uncovers the critical
importance of the hepcidin-ferroportin regulatory
axis for life and unveils the sensitivity of the exocrine
pancreas to iron overload.
INTRODUCTION
The hepcidin-ferroportin (FPN) regulatory circuitry evolved in
vertebrates to maintain physiological systemic iron levels (Hen-
tze et al., 2010). Hepcidin is a small peptide hormone secreted
by the liver in response to increased systemic iron levels or in-
flammatory cytokines. It binds to FPN, its only known receptor
(Nemeth et al., 2004). FPN is encoded by the SLC40A1 gene, a
multipass transmembrane protein that exports iron primarily
from duodenal enterocytes, reticuloendothelial macrophages,
or placental syncytiotrophoblasts into the bloodstream (Dono-
van et al., 2005; McKie et al., 2000). Hepcidin binds to the fourth
extracellular loop of FPN to trigger its ubiquitinylation on multipleCellysine residues located in the third intracellular domain (Qiao
et al., 2012). This causes ferroportin internalization and degrada-
tion in lysosomes. Low FPN expression reduces iron export into
the plasma, thus retaining iron in FPN-expressing cells and
lowering systemic iron availability (Nemeth et al., 2004).
Human ferroportin disease is an inherited iron overload disor-
der hallmarked by either loss-of-function mutations that impair
the capacity of FPN to export iron or gain-of-function mutations
that prevent hepcidin-mediated FPN control (Pietrangelo, 2004).
Gain-of-function mutations cause hereditary hemochromatosis
type 4 (HH type 4) with elevated transferrin saturation, hyperfer-
ritinemia, and tissue iron overload (Pietrangelo, 2004). In 2005, a
case of HH type 4 caused by substitution of cysteine 326 for a
serine in the FPN protein was reported (Sham et al., 2005). Func-
tional studies in cellular models suggested the critical impor-
tance of C326 for hepcidin binding (Fernandes et al., 2009).
Here, we report the generation of the first mouse model of HH
type 4 due to resistance to hepcidin. In this disease model, the
endogenous ferroportin locus was mutagenized to introduce
the C326S mutation. We demonstrate that the C326S mutation
suffices to cause resistance to hepcidin binding in vivo. A thor-
ough characterization of C326S mutant mice reveals that the
hepcidin-FPN interaction is essential to prevent fatal iron over-
load. Our study also uncovers the importance of the hepcidin-
FPN regulatory axis for proper function of the exocrine pancreas.
RESULTS AND DISCUSSION
Generation of the Slc40a1C326S Knockin Mice
We targeted the Slc40a1 locus of mouse embryonic stem cells
(ESCs) using a construct containing the C326S point mutation
in the seventh Fpn exon together with an intronic, floxed, promo-
terless b-Geo selection marker. Insertion of the b-Geo cassette
into the sixth intron of theSlc40a1 locus results in a trapped allele
(Slc40a1trap) expressing a chimeric, bicistronic mRNA from the
endogenous Slc40a1 promoter that comprises the first six Fpn
exons fused to the b-Geo marker. The Slc40a1trap mouse line
wasobtained through injectionof targetedESCs intomouseblas-
tocysts, followed by germline transmission of the targeted allele.
Southern blot analysis confirmed the proper and unique targeting
of the Slc40a1 locus (Figures 1A and 1B). To obtain the C326Sl Metabolism 20, 359–367, August 5, 2014 ª2014 Elsevier Inc. 359
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removed by crossing the Slc40a1trap line to a CRE-deletor strain
expressing CRE recombinase under the control of the constitu-
tively active Hprt promoter (Tang et al., 2002). CRE-mediated
deletion of the b-Geo cassette restores the normal ferroportin
splicing pattern and produces a mRNA that differs from wild-
type by a single point mutation introducing the C326S amino
acid substitution (Figure 1A). Effective excision of the b-Geo
sequence was ascertained by Southern blotting (Figure 1B).
Heterozygous Slc40a1wt/C326S mice were intercrossed to
generate homozygous mutant (Slc40a1C326S/C326S) and wild-
type littermates. The Slc40a1C326S allele is inherited inMendelian
proportions, in both male and female mice (Table S1).
Slc40a1C326S/C326S mice are phenotypically indistinguishable
from wild-type littermates at birth and reach adulthood without
overt abnormalities: 8- to 10-week-old animals maintained on
a standard rodent diet exhibit an overall healthy phenotype,
are fertile, have a normal body weight, and display normal
posture and behavior without evidence of neurological or
muscular impairment (data not shown).
To assess whether the C326S mutation confers the pre-
dicted resistance to hepcidin, bone marrow-derived macro-
phages (BMDMs) from 10-week-old wild-type, heterozygous
Slc40a1wt/C326S, and homozygous Slc40a1C326S/C326S mice
were either left untreated or exposed to synthetic hepcidin
(1 mg/ml) for 1–5 hr, and FPN protein expression was analyzed
by western blotting (Figure 1C). In wild-type BMDMs, FPN
expression is markedly suppressed after 1 hr exposure to hepci-
din and is no longer detected after 5 hr of treatment. Importantly,
FPN suppression by hepcidin is strongly impaired in BMDMs
from Slc40a1wt/C326S mice and completely abolished in
Slc40a1C326S/C326S cells, at least during the time course of
the experiment. Note that basal FPN levels are higher in
Slc40a1wt/C326S and Slc40a1C326S/C326S than in wild-type cells,
most likely reflecting the presence of residual amounts of hepci-
din in the culturemedium and/or endogenous production of hep-
cidin by BMDMs. Altogether, these results show that we have
created a mouse line with bona fide FPN resistance of hepcidin.
Slc40a1C326S Mice Mimic Hereditary Hemochromatosis
Type 4
A patient reported to bear a heterozygous FPN C326S mutation
suffers from juvenile HH characterized by severe hyperferremia
and hyperferritinemia (Sham et al., 2005). Young adultFigure 1. Generation of C326S-FPN Mutant Mice and Analyses of BMD
(A) Schematic representation of the Slc40a1 wild-type (WT), targeted (trap), and C
with LoxP sites (blue triangles); the mutated exon 7 bearing the C326S substituti
b-Geo internal probe (SInt) are shown. The Asp718 (Asp) and BspHI (Bsp) restric
(B) Slc40a1 wild-type (WT), targeted (trap), and C326S alleles were analyzed by
(C) BMDMs fromwild-type, Slc40a1wt/C326S, and Slc40a1C326S/C326Smice were inc
blot against FPN; b-actin (ACTB) was used as loading control.
(D) The hepatic nonheme iron content was determined in 8- and 24-week-old m
(E) Prussian blue and Perls’ staining of liver sections from 24-week-old Slc40a1w
(F) Western blot analysis of TfR1, ferritin light chain (FTL), and FPN expression
24 weeks of age. b-actin (ACTB) detection ascertained equal sample loading.
(G) Hepatic hepcidin mRNA expression was determined by quantitative RT-PCR
(H) Hepatic oxidative stress was measured as lipid peroxidation with the TBARS
(I and J) Analysis of transaminases (GPT [I] and GOT [J]) in the plasma of 24-wee
Data are reported as mean ± SEM. Student’s t test: *p < 0.05; **p < 0.01; ***p <
CelSLC40A1wt/C326S and SLC40A1C326S/C326S mice exhibit the
major hallmarks of HH type 4, with high transferrin saturation
and a marked increase in serum ferritin levels (Table 1). Consis-
tent with earlier studies of HH patients (McLaren et al., 2007),
Slc40a1C326S/C326S animals also show elevated red blood cell
counts associated with high hemoglobin and hematocrit values
and enlargedmean corpuscular volume (MCV) (Table 1). Themu-
rine C326S mutation thus recapitulates the iron overload pattern
of the same mutation and of other gain-of-function mutations in
the human ferroportin gene. Fpn is transcriptionally regulated by
zinc and copper (Chung et al., 2004; Troadec et al., 2010), and
the protein can export zinc in cellular assays (Troadec et al.,
2010). Inductively coupled plasma mass spectrometry (ICP/
MS) analysis in the plasma of Slc40a1C326S/C326S mice did not
show changes in the amount of zinc and copper (Table S2).
Sodium, calcium, and phosphate levels were also unaffected
(Table S2). Hence, FPN resistance to hepcidin and the ensuing
increase in FPN levels (see below) do not impact metal homeo-
stasis in general, but they specifically alter iron metabolism.
Hepatic Phenotype of Hepcidin-Resistant Animals
Iron deposition in the liver of untreated HH patients causes pro-
gressive hepatic damage and increases the risk of cirrhosis and
hepatocellular carcinoma (Pietrangelo, 2010). Compared towild-
type, Slc40a1wt/C326S and Slc40a1C326S/C326S mice display a
dramatic increase in hepatic iron levels, regardless of gender
(Figure 1D). Prussian blue staining reveals preferential iron depo-
sition in the pericentral areas of the liver lobules (Figure 1E, top),
which is associated with reduced FPN expression in this area
(Figure S1C, available online). Perls’ staining shows that iron
accumulates exclusively in hepatocytes (Figure 1E, bottom).
Kupffer cells, specialized iron-exporting macrophages located
in hepatic sinusoids, are iron spared (Figure 1E, bottom); this is
consistent with the C326S form of FPN being constitutively over-
expressed in macrophages (Figure S1C) and exporting iron into
the bloodstream in an uncontrolled manner.
Hepatic iron loading downregulates transferrin receptor 1
(TfR1) (Figures 1F and S1A) and stimulates expression of the
iron storage protein ferritin light chain (FtL) (Figure 1F). These
effects likely reflect iron regulatory protein/iron responsive
element (IRP/IRE)-dependent regulation of TFR1 and FtL in he-
patocytes (Hentze and Ku¨hn, 1996). C326S mutant mice also
overexpress FPN compared to wild-type, with the highest
expression in Slc40a1C326S/C326S animals and intermediateM and Liver
326S loci together with the targeting construct. The b-Geo cassette is flanked
on (indicated with 7*) is represented in red. The 50 external probe (S5) and the
tion sites are indicated.
Southern blotting using the indicated restriction enzymes and probes.
ubated with synthetic hepcidin for the time indicated and subjected to western
ice.
t/wt and Slc40a1C326S/C326S male mice. KC, Kupffer cells.
in the liver of Slc40a1wt/wt, Slc40a1wt/C326S, and Slc40a1C326S/C326S mice at
(qRT-PCR) and calibrated to b-actin mRNA levels.
assay and normalized against total protein amount.
k-old animals.
0.001; ****p < 0.0001. See also Figure S1 and Table S1.
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Table 1. Plasma Iron Levels and Hematological Parameters in 10-Week-Old Mice
Parameter
Males Females
WT/WT n WT/C326S n C326S/C326S n WT/WT n WT/C326S n C326S/C326S n
Plasma Fe (mg/dl) 129.7 ± 7.8 6 353.5 ± 12.1**** 5 350.7 ± 5.1**** 6 166.4 ± 3.8 6 330.4 ± 12.4**** 6 332.1 ± 10.2**** 5
UIBC (mg/dl) 178.9 ± 6.7 6 42.6 ± 7.8**** 5 37.6 ± 8.5**** 6 179.5 ± 5.6 6 28.1 ± 2.1**** 6 18.4 ± 4.5**** 5
TfSat (%) 42.0 ± 2.1 6 89.4 ± 1.7**** 5 90.6 ± 1.8**** 6 48.1 ± 1.1 6 92.1 ± 0.7**** 6 94.8 ± 1.2**** 5
Ferritin (ng/ml) 137.9 ± 17.4 6 684.2 ± 123.3*** 4 1,748 ± 524* 6 189 ± 10.5 6 735.5 ± 123.6** 6 739.4 ± 124.0*** 5
RBC (1012/l) 9.78 ± 0.09 12 10.23 ± 0.07*** 12 10.33 ± 0.16** 10 10.00 ± 0.10 11 10.04 ± 0.19 12 10.15 ± 0.04 7
Hb (g/dl) 15.71 ± 0.15 12 16.91 ± 0.15**** 12 17.19 ± 0.13**** 10 16.13 ± 0.15 11 16.79 ± 0.23* 12 16.74 ± 0.25* 7
Hct (%) 50.7 ± 0.6 12 55.1 ± 0.4**** 12 55.3 ± 0.8**** 10 52.1 ± 0.5 11 53.6 ± 1.0 12 53.9 ± 0.2* 7
MCV (fl) 51.8 ± 0.3 12 54.1 ± 0.2**** 12 53.6 ± 0.4** 10 52.1 ± 0.2 11 53.3 ± 0.2*** 12 53.3 ± 0.2** 7
MCH (pg) 16.1 ± 0.1 12 16.5 ± 0.1** 12 16.7 ± 0.1 10 16.1 ± 0.1 11 16.8 ± 0.2** 12 16.5 ± 0.2 7
MCHC (g/dl) 30.99 ± 0.15 12 30.68 ± 0.13 12 31.10 ± 0.43 10 30.98 ± 0.18 11 31.40 ± 0.33 12 31.03 ± 0.38 7
UIBC, unsaturated iron binding capacity; TfSat, transferrin saturation; RBC, red blood cell; Hb, hemoglobin; Hct, hematocrit; MCV, mean corpuscular
volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration. Data are reported as mean ± SEM. Student’s
t test: *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001. See also Table S2.
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plained by decreased turnover of the hepcidin-insensitive FPN
mutant protein (Figure S1C) but is also partly due to increased
FPN transcript levels (Figure S1A); derepression of FPN transla-
tion by iron-mediated inhibition of the IRP/IRE system (McKie
et al., 2000) may also contribute. Importantly, Slc40a1wt/C326S
and Slc40a1C326S/C326S mice express levels of hepcidin mRNA
in the liver significantly higher than those of wild-type (Figure 1G),
associated with an increased expression of BMP6, ID1, SMAD6,
and SMAD7 mRNAs (Figure S1A). These responses show that
hepatocytes of C326S mutant mice adequately sense the iron
overload and activate the BMP/SMAD signaling pathway with
the concomitant expression of Hepcidin. Yet, the hepcidin
response remains ineffective because the hormone fails to
bind its receptor FPN. This phenotype is consistent with sys-
temic and hepatic iron overload of patients with HH type 4 in
spite of elevated hepcidin levels (Sham et al., 2009). These
data also support the notion that hepcidin controls iron meta-
bolism largely or exclusively through interaction with FPN.
Iron excess elicits its deleterious effects by promoting the gen-
eration of reactive oxygen species (ROS), which cause damage
to proteins, DNA, and lipids (Altamura and Muckenthaler, 2009).
Iron loading in the liver of 24-week-old Slc40a1wt/C326S and
Slc40a1C326S/C326S animals is associated with marked lipid per-
oxidation, as evidenced by their substantial increase in thiobar-
bituric acid reactive substances (TBARS) (Figure 1H). Yet, blood
levels of alanine transaminase remain within the normal range
(Figure 1I), and aspartate transaminase is only mildly increased
in female mice (Figure 1J). Furthermore, we observed no histo-
logical sign of liver damage (Figure S1B). These results show
that hepatic iron loading in C326S mutant animals does not
impair liver integrity and function (at least up to 24 weeks of
age). These findings support the notion that mice, unlike pa-
tients, are protected from liver damage even in the context of
severe tissue iron overload by as-yet-unknown mechanisms.
Unrestrained Iron Export from Macrophages and
Enterocytes in C326S Mutant Mice
Splenic macrophages recycle iron from senescent red blood
cells and export the metal into the bloodstream via FPN (Dono-362 Cell Metabolism 20, 359–367, August 5, 2014 ª2014 Elsevier Incvan et al., 2000). C326S FPN mutant mice exhibit decreased
splenic iron levels at 8 and 24 weeks of age (Figure 2A). Perls’
staining of spleen sections reveals selective iron depletion within
iron-recycling macrophages of the red pulp (Figure 2B). Iron
depletion of macrophages is further evidenced by decreased
FtL expression in the spleen (Figure 2C, middle). These alter-
ations are attributed to the constitutive, abnormally high ex-
pression of the FPN iron exporter (Figure 2C, top). FPN is
overexpressed in spite of highly elevated Hepcidin expression
(Figure 1G), again demonstrating that the C326S mutation ren-
ders FPN insensitive to hepcidin in vivo, as observed ex vivo in
BMDMs (Figure 1C). Iron depletion of macrophages is predicted
to activate iron regulatory proteins, inhibit ferritin translation (see
above), and also repress the translation of FPN mRNA (McKie
et al., 2000). If this occurs, the degree of repression is notably
insufficient to prevent the overexpression of hepcidin-insensitive
FPN, uncontrolled iron export from macrophages, and systemic
iron overload, implying that the regulation of body iron recycling
by hepcidin prevails. Notably, mice carrying either one or two
copies of the C326S Fpn allele display similar levels of Fpn
expression (Figure 2C) and similar levels of iron depletion in the
spleen (Figure 2A). This suggests that the C326Smutation exerts
a functionally dominant effect in splenic macrophages.
FPN is also expressed in duodenal enterocytes, where it me-
diates the transport of dietary iron into the bloodstream (McKie
et al., 2000). Similar to the reticuloendothelial macrophages (Fig-
ures 2A and 2B), the intestinal epithelium of Slc40a1C326S/C326S
animals is iron depleted compared to wild-type (Figure 2D,
top). This iron depletion is associated with overexpression of
the C326S FPN mutant protein (Figure 2E, middle) that accumu-
lates at the basolateral side of enterocytes (Figure 2D, middle).
FPN mRNA levels are also increased (Figure 2F), and thus both
transcriptional (Taylor et al., 2011) and posttranslational regula-
tory mechanisms, due to the hepcidin resistance, appear to
contribute to high FPN expression in the intestine of C326S
mutant animals. The increased FPN expression is accompanied
by an elevation of the iron uptake protein DMT1 (Figure 2E, top)
at the apical membrane of enterocytes (Figure 2D, bottom).
DMT1 expression is augmented at least in part at the mRNA
level, as indicated by the DMT1-1A (Figure 2G) and -IRE.
(legend on next page)
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animals is likely unrelated to IRP control of DMT1mRNA turnover
(Galy et al., 2013) and most likely reflects stabilization of the
HIF2a transcription factor in iron-depleted enterocytes and sub-
sequent enhancement of Dmt1 transcription (Mastrogiannaki
et al., 2009). This notion is further supported by the increased
expression of Dcytb ferric reductase (Figure 2I), another HIF2a
target gene (Mastrogiannaki et al., 2009). Interestingly, DMT1
expression in enterocytes is augmented (Figures 2D and 2E) in
spite of high hepcidin levels (Figure 1G). Hepcidin has been pro-
posed to directly target DMT1 for degradation in enterocytes
ex vivo (Brasse-Lagnel et al., 2011), but our data indicate that
such amechanism, if effective in vivo, fails to efficiently suppress
the apical iron uptakemachinery in the duodenum of C326S FPN
mutant mice.
In contrast to the spleen (Figure 2C, top), duodenal entero-
cytes from Slc40a1C326S/C326S mice display a stronger increase
in FPN protein levels compared to Slc40a1wt/C326S (Figure 2E,
middle). This suggests that the C326S FPNmutation is not domi-
nant in the intestine. Consequently, Slc40a1C326S/C326S mice
may export more dietary iron into the blood stream than
Slc40a1wt/C326S littermates, while the iron export capacity of
macrophages seems the same. Differences in systemic iron
accumulation between Slc40a1wt/C326S and Slc40a1C326S/C326S
mice are not accounted for by differences in transferrin satura-
tion (Table 1), which is close to 100% in both genotypes.
Possibly, circulating nontransferrin bound iron (NTBI) may be
increased in Slc40a1C326S/C326S mice. This is reflected on the
organ level, whereby kidney (Figure S2A), heart (Figure S2B),
pancreas (see below), and brain (Figure S2C) accumulate more
iron in Slc40a1C326S/C326S than Slc40a1wt/C326S animals. Iron in
the kidney accumulates predominantly in the renal medulla (Fig-
ure S2D), while in the heart the metal is detected mainly in
vascular smooth muscle cells (Figure S2E). Accumulation of
brain iron is detected in the choroid plexus (Figure S2F).
Taken together, the analyses of C326S FPNmutant mice yield
insight into the hierarchy of iron regulatory mechanisms opera-
tional in iron-exporting cell types and uncover the dominant
role of the FPN-hepcidin axis for systemic iron homeostasis
in vivo.
Hepcidin Binding to FPN Is Critical for Exocrine
Pancreatic Function and Organismal Survival
The necropsy of Slc40a1C326S/C326S mice revealed not only the
expected dark brown coloration of the liver, but also dark
brown coloration of the pancreas, suggestive of iron deposition
(Figure 3A). Indeed, C326S FPN mutant mice show progressive
and marked iron accumulation in the pancreatic tissue (Fig-Figure 2. Analysis of Spleen and Duodenum
(A) Splenic nonheme iron was measured in 8- and 24-week-old mice.
(B) Perls’ staining showing iron depletion in macrophages of the red pulp (RP) in
(C) Western blot analysis of FPN and ferritin light chain (FTL) expression in the sp
(D) Perls’ staining (top) showing low iron levels in the duodenum of 24-week-old
(middle) and DMT1 (bottom) at the basolateral and apical membrane of enterocy
(E) Western blot analysis of DMT1 and FPN protein expression in the duodenum
equal sample loading.
(F–I) qRT-PCR analysis of Fpn (F), DMT1-1A (G), DMT1-IRE (H), and Dcytb (I) mR
Data are reported as mean ± SEM. Student’s t test: *p < 0.05; **p < 0.01; ***p <
364 Cell Metabolism 20, 359–367, August 5, 2014 ª2014 Elsevier Incure 3B). Consistently, TFR1 protein levels are decreased, while
ferritin light (FtL) and heavy (FtH) chain expression is
augmented (Figure 3F), as expected in iron overloaded cells.
Similar to the liver (Figure 1H), iron accumulation in the
pancreas triggers oxidative stress (Figure 3C). Interestingly,
Perls’ staining reveals preferential iron accumulation in the
exocrine pancreas, sparing the islets of Langerhans (Figure S3A,
top) that seem to function properly, as evidenced by normal
oral glucose and insulin tolerance tests (Figure S3B). Iron
loading of the exocrine pancreas without impact on glucose ho-
meostasis has been reported for other mouse models of HH
associated with absent or low hepcidin, such as Hamp/
and Hjv/ mice (Huang et al., 2005; Ramey et al., 2007). How-
ever, Slc40a1C326S/C326S animals differ from those HH models
by clear signs indicating exocrine pancreatic failure. Indeed,
hematoxylin and eosin staining demonstrates degeneration of
the pancreatic acini starting at 21 weeks of age (Figure S3D)
and worsening thereafter, with severe tissue degeneration in
7-month-old animals (Figure 3D). At 10 months of age, the
degeneration becomes dramatic even though no signs of
fibrosis were observed (Figure S3A, bottom). Consistent with
a severely damaged exocrine pancreas, Slc40a1C326S/C326S
mice show markedly reduced levels of lytic pancreatic enzymes
such as amylase and elastase (Figure 3F). Increased plasma
levels of pancreatic lipase (Figure 3E) further document the
loss of integrity of the exocrine pancreas.
To understand why iron accumulates preferentially in the
exocrine pancreas, we analyzed iron trafficking proteins by
immunohistochemistry. Interestingly, TfR1 and DMT1 are pre-
dominantly detected in the endocrine pancreas of wild-
type mice, and their expression is strongly reduced in
Slc40a1C326S/C326S animals (Figure S3C). Hence, the severe
iron accumulation in the exocrine pancreas ofSlc40a1C326S/C326S
mice cannot be explained by DMT1 and TFR1 overexpression
and could plausibly be due to increased uptake of nontransferrin
bound iron, e.g., via ZIP14, which is expressed on the plasma
membrane of acinar cells of rats and is upregulated in response
to iron overload (Nam et al., 2013). Importantly, FPN is detected
in the endocrine pancreas of wild-type animals, and its expres-
sion persists in C326S mutant mice (Figure S3C). This finding
provides a possible explanation for why the islets of Langerhans
are iron spared and glucose homeostasis is unaltered. Notably,
FPN is also detected on the surface of a restricted number of
acinar cells (Figure S3C) in Slc40a1C326S/C326S mice, suggesting
that those cells that lack Fpn expression may be prone to iron
accumulation and oxidative stress and destined for degenera-
tion. However, it remains unclear what drives FPN expression in
some acinar cells and not others.the spleen of 24-week-old Slc40a1C326S/C326S male mice.
leen of 24-week-old animals. b-actin (ACTB) was used as loading control.
Slc40a1C326S/C326S male mice; IHC analyses showing high amounts of FPN
tes.
at 24 weeks of age. Mouse genotype is indicated. b-actin (ACTB) ascertained
NA in the duodenum of 24-week-old mice.
0.001; ****p < 0.0001. See also Figure S2.
.
Figure 3. Systemic Iron Overload Causes
Fatal Pancreatic Failure in C326S FPN
Mutant Mice
(A) Macroscopical analysis showing strong brown
coloration of the liver (plain arrow) and pancreas
(empty arrow) of 27-week-old Slc40a1C326S/C326S
mice, suggestive of iron deposition.
(B) Nonheme iron levels in the pancreas of wild-
type and C326S FPNmutant mice at 8 or 24 weeks
of age.
(C) TBARS assay showing increased lipid peroxi-
dation and thus oxidative stress in pancreas of 24-
week-old mice; TBARS levels were normalized
against total protein content.
(D) Hematoxylin and eosin (H&E, top) and Prussian
blue iron (bottom) staining of pancreatic sections
from 35-week-old mice; the light purple color
(black arrow) in H&E stained sections of mutant
mice shows the degeneration of acinar cells.
(E) Plasma levels of pancreatic lipase in 24-week-
old mice.
(F) Western blot analysis of TFR1, ferritin light
(FTL) and heavy (FTH) chain, amylase (Amyl), and
pancreatic elastase (Ela3) expression in the
pancreas of wild-type, heterozygous, and homo-
zygous C326S FPN mutant mice at 28 weeks of
age; b-actin (ACTB) has been used as loading
control. The western blot signals were quantified,
and the results are shown as histograms.
(G) Body weight at 27 weeks of age.
(H) Kaplan-Meier survival curve showing prema-
ture death in Slc40a1C326S/C326S homozygous
mice.
(I) Slc40a1C326S/C326S male mice (16 weeks old)
weremaintained on a control (200 ppm iron) versus
low-iron diet (<10 ppm iron), or on a control diet
supplemented with the Pancrex preparation. Body
weight was determined weekly and reported.
(J) Kaplan-Meier survival curve of mice subjected
to different dietary treatments as indicated in (I).
Log rank Mantel-Cox test p value is indicated.
Data are reported asmean ± SEM. Student’s t test:
*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.
See also Figure S3.
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healthy in early adulthood, both male and female C326S FPN
mutant animals display a substantial wasting at 27 weeks of
age (Figure 3G). This weight loss could be explained by
malabsorption as a result of insufficient production of digestiveCell Metabolism 20, 359–3enzymes by the failing exocrine pan-
creas (see below). In sharp contrast
with the previously reported mouse
models with systemic iron overload,
Slc40a1C326S/C326S animals have a
shorter lifespan than control littermates
and start to die from 7months of age (Fig-
ure 3H). Death is preceded by a sudden
and profound loss of body weight down
to 17–20 g, with mice humping the back
and manifesting clear signs of sickness.
Hence, FPN resistance to hepcidin is
lethal in mice.Compared to Slc40a1C326S/C326S animals, Slc40a1wt/C326S
mice exhibit overall a much weaker pancreatic phenotype, with
less iron accumulation (Figure 3B), less oxidative stress (Fig-
ure 3C), reduced plasma lipase levels (Figure 3E), and a minor
decrease in amylase and elastase (Figure 3F). These milder67, August 5, 2014 ª2014 Elsevier Inc. 365
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Ferroportin Resistance to Hepcidin Is Lethalalterations do not cause the pathologies observed in
Slc40a1C326S/C326S mice and allow for a normal lifespan (Fig-
ure 3H). Notably, exocrine pancreatic failure was also not re-
ported for patients with HH type 4, who carry heterozygous
FPN gain-of-function mutations.
To directly test the hypothesis that body weight loss and pre-
mature death of FPN C326S homozygous mutant animals are
due to iron overload, Slc40a1C326S/C326S mice were maintained
on an iron-deficient (<10 ppm iron) versus standard diet (200
ppm iron) starting from 16 weeks of age. As shown in Figures
3I and 3J, the low-iron diet completely prevents the body weight
loss and restores survival. These findings demonstrate that
Slc40a1C326S/C326S mice indeed succumb to iron overload.
To further test whether exocrine pancreatic failure is a leading
cause of wasting and death, the standard chow was supple-
mented with Pancrex, a compound commonly used clinically in
pancreatic enzyme replacement therapy (PERT) (Fieker et al.,
2011). PERT significantly ameliorated the condition of
Slc40A1C326S/C326S mice, with partial reversion of body weight
loss (Figure 3I) and improved survival (Figure 3J). Iron overload-
ing and failure of the exocrine pancreas thus contribute to the
weight loss and premature lethality of Slc40a1C326S/C326S mice.
While the effect of Pancrex is obvious, it is not complete. The
partial effectiveness could result from a still suboptimal PERT
protocol but is likely also due to the mode of action of Pancrex,
which corrects only some of the digestive consequences of
pancreatic degeneration but leaves the mice with a severely
damaged organ. Furthermore, additional yet-unidentified factors
could also contribute to mouse wasting and death.
Our study shows that a single C326S substitution in FPN
causes resistance to hepcidin in vivo and ex vivo, recapitulating
key features of human HH type 4. It also uncovers the critical
importance of the hepcidin-FPN regulatory circuitry for organ-
ismal survival. In contrast to previously reported mouse models
of dietary systemic iron overload, the C326S FPN line shows
shortened lifespan.
The absence of a hormone or the disruption of binding to its
receptor could in principle yield identical phenotypes. FPN
C326S mice and Hamp/ animals display similar phenotypic
abnormalities, such as iron accumulation in liver, pancreas,
and kidney, and iron depletion in duodenum and spleen (Les-
bordes-Brion et al., 2006; Moulouel et al., 2013). However,
Hamp/ mice notably have not been reported to die prema-
turely and hence do not phenocopy C326S FPN mutant animals
completely. This difference suggests that additional functions of
hepcidin, modes of regulation of FPN, and/or genetic modifiers
of iron-mediated lethality are to be discovered.EXPERIMENTAL PROCEDURES
Mice
Unless specified, all mice analyzed were on a mixed 129P2/C57BL6 genetic
background, and wild-type littermates were used as controls. Mice were
housed in the EMBL animal facility under a constant light-dark cycle andmain-
tained on a standard mouse diet containing 200 ppm iron (Teklad 2018S,
Harlan) with ad libitum access to food and water. Custom low-iron (E15510-
24), control (E15510-24 supplemented with 200 ppm iron), and Pancrex
(E15510-24 supplemented with 200 ppm iron and 10 g/kg Pancrex) chows
were obtained from SSNIFF GmbH and given to B6N8F2 mice. Heparinized
blood was collected by cardiac puncture from mice euthanized by CO2 inha-366 Cell Metabolism 20, 359–367, August 5, 2014 ª2014 Elsevier Inclation. For molecular analyses, mice were sacrificed by cervical dislocation
to avoid proteome degradation. All mouse breeding and animal experiments
were approved by and conducted in compliance with the guidelines of the
EMBL Institutional Animal Care and Use Committee.
Isolation of BMDM and Hepcidin Treatment
Bone marrow cells were flushed from tibia and femur using ice-cold Hank’s
balanced salt solution (HBSS) and filtered through a 70 mm cell strainer. Cells
were seeded at a density of 350,000 cells/cm2 in RPMI1640-Glutamax
medium (Life Technologies) supplemented with 10% of heat-inactivated fetal
bovine serum (Thermo), 1% penicillin/streptomycin (Sigma), and 10 ng/ml
M-CSF1 (Sigma). After 4 days, nonadherent cells were removed by HBSS
washing, and the medium was replaced daily until cell harvesting (typically
6–7 days after seeding). Hepcidin treatment was performed as indicated using
synthetic hepcidin 25 (Peptides International).
Hematology, Plasma Biochemistry, and Tissue Iron Quantification
Hematological parameters were determined using the ABC ScilVet analyzer
(ABX Diagnostics). Plasma iron concentrations and unsaturated iron binding
capacity were assessed using the SFBC and UIBC kits (Biolabo). Transferrin
saturation was calculated using the formula SFBC / (SFBC + UIBC) 3 100.
Plasma ferritin measurements were performed using an Olympus AU400
analyzer at the Claude Bernard Institute (Paris, France). Plasma lipase, GOT,
GTP, urea, creatinine, Na, K, and P were measured with a Hitachi 917E
analyzer. Plasma Zn and Cu were measured by ICP/MS. Tissue nonheme
iron content was measured using the bathophenanthroline method and calcu-
lated against dry weight tissue (Torrance and Bothwell, 1968).
Isolation of BMDMs and Hepcidin Treatment
Bonemarrow cells were flushed from tibia and femur using ice-cold HBSS and
filtered through a 70 mmcell strainer. Cells were seeded at a density of 350,000
cells/cm2 in RPMI1640-Glutamax medium (Life Technologies) supplemented
with 10% of heat-inactivated FBS (Thermo), 1% penicillin/streptomycin
(Sigma), and 10 ng/ml M-CSF1 (Sigma). After 4 days, nonadherent cells
were removed by HBSS washing, and the medium was replaced daily until
cell harvesting (typically 6–7 days after seeding). Hepcidin treatment was per-
formed as indicated using synthetic hepcidin 25 (Peptides International).
Immunohistochemistry
Tissues obtained from adult mice were fixed for 24 hr in 10% neutral buffered
formalin (Sigma), dehydrated, and paraffin embedded. Tissue sections (4 mm)
were mounted on Polysine slides (Thermo Scientific), rehydrated, and treated
for 10 min with 3% H2O2 (Sigma) to block the endogenous peroxidases. After
washing in distilled water, tissue slides were subjected to microwave-medi-
ated antigen retrieval using the Citraplus reagent (Biogenex). After 40 min of
cooling, slides were washed three times in PBS and subjected to immunore-
cognition using the Vectastain ABC mouse and rabbit kits (Vector Labs)
following manufacturer’s instructions. Antibody dilution and catalog number
are reported in the Supplemental Experimental Procedures. Tissue slides
have been developed using the Vector AEC substrate (Vector labs), rinsed
with distilled water, counterstained with hematoxylin, washed in PBS, and
mounted using the VectaMount AQ mounting medium (Vector Labs).
Western Blotting
Protein lysates were obtained by homogenizing snap-frozen tissues in RIPA
buffer supplemented with protease inhibitors (Roche) as described (Galy
et al., 2004). Protein concentration was determined using the DC protein assay
(BioRad). Total protein (50 mg) was subjected to western blot analysis with the
antibodies listed in the Supplemental Experimental Procedures. Western blot
images were acquired and quantified with the Vilber Lourmat Fusion-FX sys-
tem and normalized to b-actin (ACTB).
RNA Extraction, Reverse Transcription, and qRT-PCR
Total RNA was isolated using TRIzol (Life Technologies), reverse transcribed,
and used in SYBR green qPCR, as described (Altamura et al., 2010). mRNA
expression was calculated relative to b-actin, and data were analyzed using
the DDCt method (Livak and Schmittgen, 2001). The primers used are listed
in the Supplemental Experimental Procedures..
Cell Metabolism
Ferroportin Resistance to Hepcidin Is LethalStatistical Analyses
Data are shown as mean ± SEM, and the number of mice (n) is indicated.
Statistical analyses were performed using Prism v.6 (GraphPad). Two-tailed
Student’s t test p value was calculated against sex-matched wild-type mice.
*p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 are indicated.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.cmet.2014.07.007.
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